290 related articles for article (PubMed ID: 31169523)
21. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of cholestatic liver disease].
Pleşa A
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
[TBL] [Abstract][Full Text] [Related]
23. Novel developments in IBD-related sclerosing cholangitis.
Ponsioen CY
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925
[TBL] [Abstract][Full Text] [Related]
24. Primary sclerosing cholangitis: updates in diagnosis and therapy.
Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
[TBL] [Abstract][Full Text] [Related]
25. Stratified medicine and primary biliary cholangitis.
Mells GF; Jones DE
Lancet Gastroenterol Hepatol; 2017 May; 2(5):319-321. PubMed ID: 28397694
[No Abstract] [Full Text] [Related]
26. Primary sclerosing cholangitis.
Geonzon-Gonzales MR
Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
[TBL] [Abstract][Full Text] [Related]
28. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of primary biliary cholangitis.
Laschtowitz A; de Veer RC; Van der Meer AJ; Schramm C
United European Gastroenterol J; 2020 Jul; 8(6):667-674. PubMed ID: 32299307
[TBL] [Abstract][Full Text] [Related]
30. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation.
Boner AL; Peroni D; Bodini A; Delaini G; Piacentini G
Int J Immunopathol Pharmacol; 2007; 20(4):847-9. PubMed ID: 18179759
[TBL] [Abstract][Full Text] [Related]
31. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
Fracchia M; Soubrane O; Houssin D; Galatola G
Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
[TBL] [Abstract][Full Text] [Related]
32. Novel Treatment Strategies for Primary Biliary Cholangitis.
Parés A
Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
[TBL] [Abstract][Full Text] [Related]
33. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
34. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
35. Treatment options for primary sclerosing cholangitis.
Sinakos E; Lindor K
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
[TBL] [Abstract][Full Text] [Related]
36. Primary sclerosing cholangitis and bile acids.
Chazouillères O
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S21-5. PubMed ID: 23141889
[TBL] [Abstract][Full Text] [Related]
37. Primary sclerosing cholangitis.
Zein CO; Lindor KD
Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
[TBL] [Abstract][Full Text] [Related]
38. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.
Angulo P; Therneau TM; Jorgensen A; DeSotel CK; Egan KS; Dickson ER; Hay JE; Lindor KD
J Hepatol; 1998 Nov; 29(5):729-35. PubMed ID: 9833910
[TBL] [Abstract][Full Text] [Related]
39. Primary sclerosing cholangitis.
Stiehl A; Benz C; Sauer P
Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid therapy in hepatobiliary disease.
Kowdley KV
Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
